Permit Capital’s Gilead Sciences GILD Stock Holding History

Permit Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-33,700	Closed	-$2.14M	–	25
2019 Q3	$2.14M	Hold	33,700	–	–	0.91%	12
2019 Q2	$2.28M	Hold	33,700	–	–	1.01%	13
2019 Q1	$2.19M	Hold	33,700	–	–	1.02%	13
2018 Q4	$2.11M	Hold	33,700	–	–	1.26%	12
2018 Q3	$2.6M	Hold	33,700	–	–	1.39%	12
2018 Q2	$2.39M	Hold	33,700	–	–	1.29%	12
2018 Q1	$2.54M	Hold	33,700	–	–	1.41%	10
2017 Q4	$2.41M	Hold	33,700	–	–	1.3%	13
2017 Q3	$2.73M	Hold	33,700	–	–	1.61%	13
2017 Q2	$2.38M	Hold	33,700	–	–	1.4%	15
2017 Q1	$2.29M	Hold	33,700	–	–	1.46%	14
2016 Q4	$2.41M	Hold	33,700	–	–	1.65%	13
2016 Q3	$2.67M	Hold	33,700	–	–	1.8%	13
2016 Q2	$2.81M	Buy	33,700 +5,900	+21%	+$524K	2%	11
2016 Q1	$2.55M	Buy	27,800 +16,600	+148%	+$1.5M	1.93%	13
2015 Q4	$1.13M	Buy	11,200 +4,000	+56%	+$416K	0.84%	16
2015 Q3	$707K	Buy	+7,200	New	+$800K	0.48%	25

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Permit Capital's GILD Position: Q4 2019 in Review

Permit Capital sold out of Gilead Sciences (GILD) in Q4 2019, closing a stake of 33,700 shares — an estimated $2.14M sold.

Permit Capital first reported a position in GILD in Q3 2015 and held it in 17 quarters. The position peaked at $2.81M in Q2 2016. 1,555 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

Permit Capital reported no remaining Gilead Sciences position as of Q4 2019 after selling out during the quarter.
Permit Capital sold 33,700 Gilead Sciences shares in Q4 2019, an estimated $2.14M.
Permit Capital first reported a position in Gilead Sciences in Q3 2015 and held it in 17 quarters.
Permit Capital's Gilead Sciences position peaked at $2.81M in Q2 2016.
1,555 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on Permit Capital's 13F filing for Q4 2019, filed 14 Feb 2020.